Abbey E Poirier1, Anne Grundy1, Farah Khandwala1, Christine M Friedenreich1, Darren R Brenner1. 1. Affiliations: Department of Cancer Epidemiology and Prevention Research (Poirier, Grundy, Khandwala, Friedenreich, Brenner), CancerControl Alberta, Alberta Health Services; Department of Oncology (Friedenreich, Brenner) and Department of Community Health Sciences (Friedenreich, Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.
Abstract
BACKGROUND: The International Agency for Research on Cancer has classified outdoor air pollution (fine particulate matter [PM2.5]) as a Group 1 lung carcinogen in humans. We aimed to estimate the proportion of lung cancer cases attributable to PM2.5 exposure in Alberta in 2012. METHODS: Annual average concentrations of PM2.5 in 2011 for 22 communities across Alberta were extracted from the Clean Air Strategic Alliance Data Warehouse and were population-weighted across the province. Using 7.5 µg/m3 and 3.18 µg/m3 as the annual average theoretical minimum risk concentrations of PM2.5, we estimated the proportion of the population above this cut-off to determine the population attributable risk of lung cancer due to PM2.5 exposure. RESULTS: The mean population-weighted concentration of PM2.5 for Alberta in 2011 was 10.03 µg/m3. We estimated relative risks of 1.02 and 1.06 for theoretical minimum risk PM2.5 concentration thresholds of 7.5 µg/m3 and 3.18 µg/m3, respectively. About 1.87%-5.69% of incident lung cancer cases in Alberta were estimated to be attributable to PM2.5 exposure. INTERPRETATION: Our estimate of attributable burden is low compared to that reported in studies in other areas of the world owing to the relatively low levels of PM2.5 recorded in Alberta. Reducing PM2.5 emissions in Alberta should continue to be a priority to help decrease the burden of lung cancer in the population. Copyright 2017, Joule Inc. or its licensors.
BACKGROUND: The International Agency for Research on Cancer has classified outdoor air pollution (fine particulate matter [PM2.5]) as a Group 1 lung carcinogen in humans. We aimed to estimate the proportion of lung cancer cases attributable to PM2.5 exposure in Alberta in 2012. METHODS: Annual average concentrations of PM2.5 in 2011 for 22 communities across Alberta were extracted from the Clean Air Strategic Alliance Data Warehouse and were population-weighted across the province. Using 7.5 µg/m3 and 3.18 µg/m3 as the annual average theoretical minimum risk concentrations of PM2.5, we estimated the proportion of the population above this cut-off to determine the population attributable risk of lung cancer due to PM2.5 exposure. RESULTS: The mean population-weighted concentration of PM2.5 for Alberta in 2011 was 10.03 µg/m3. We estimated relative risks of 1.02 and 1.06 for theoretical minimum risk PM2.5 concentration thresholds of 7.5 µg/m3 and 3.18 µg/m3, respectively. About 1.87%-5.69% of incident lung cancer cases in Alberta were estimated to be attributable to PM2.5 exposure. INTERPRETATION: Our estimate of attributable burden is low compared to that reported in studies in other areas of the world owing to the relatively low levels of PM2.5 recorded in Alberta. Reducing PM2.5 emissions in Alberta should continue to be a priority to help decrease the burden of lung cancer in the population. Copyright 2017, Joule Inc. or its licensors.
Authors: Michelle C Turner; Daniel Krewski; C Arden Pope; Yue Chen; Susan M Gapstur; Michael J Thun Journal: Am J Respir Crit Care Med Date: 2011-10-06 Impact factor: 21.405
Authors: C Arden Pope; Richard T Burnett; Michael J Thun; Eugenia E Calle; Daniel Krewski; Kazuhiko Ito; George D Thurston Journal: JAMA Date: 2002-03-06 Impact factor: 56.272
Authors: Daniel Krewski; Michael Jerrett; Richard T Burnett; Renjun Ma; Edward Hughes; Yuanli Shi; Michelle C Turner; C Arden Pope; George Thurston; Eugenia E Calle; Michael J Thun; Bernie Beckerman; Pat DeLuca; Norm Finkelstein; Kaz Ito; D K Moore; K Bruce Newbold; Tim Ramsay; Zev Ross; Hwashin Shin; Barbara Tempalski Journal: Res Rep Health Eff Inst Date: 2009-05
Authors: Paulo H N Saldiva; Robert W Clarke; Brent A Coull; Rebecca C Stearns; Joy Lawrence; G G Krishna Murthy; Edgar Diaz; Petros Koutrakis; Helen Suh; Akira Tsuda; John J Godleski Journal: Am J Respir Crit Care Med Date: 2002-06-15 Impact factor: 21.405
Authors: Dan L Crouse; Paul A Peters; Perry Hystad; Jeffrey R Brook; Aaron van Donkelaar; Randall V Martin; Paul J Villeneuve; Michael Jerrett; Mark S Goldberg; C Arden Pope; Michael Brauer; Robert D Brook; Alain Robichaud; Richard Menard; Richard T Burnett Journal: Environ Health Perspect Date: 2015-11-01 Impact factor: 9.031
Authors: Ghassan B Hamra; Neela Guha; Aaron Cohen; Francine Laden; Ole Raaschou-Nielsen; Jonathan M Samet; Paolo Vineis; Francesco Forastiere; Paulo Saldiva; Takashi Yorifuji; Dana Loomis Journal: Environ Health Perspect Date: 2014-06-06 Impact factor: 9.031
Authors: Richard T Burnett; C Arden Pope; Majid Ezzati; Casey Olives; Stephen S Lim; Sumi Mehta; Hwashin H Shin; Gitanjali Singh; Bryan Hubbell; Michael Brauer; H Ross Anderson; Kirk R Smith; John R Balmes; Nigel G Bruce; Haidong Kan; Francine Laden; Annette Prüss-Ustün; Michelle C Turner; Susan M Gapstur; W Ryan Diver; Aaron Cohen Journal: Environ Health Perspect Date: 2014-02-11 Impact factor: 9.031
Authors: Susan Lavinia Greco; Elaina MacIntyre; Stephanie Young; Hunter Warden; Christopher Drudge; JinHee Kim; Elisa Candido; Paul Demers; Ray Copes Journal: BMC Public Health Date: 2020-06-26 Impact factor: 3.295